Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRGF-ENDORET for Low Back Pain
NCT06715085Phase 4Recruiting
- Sponsor
- BTI Biotechnology Institute
- Start
- Jan 2025
- Primary completion
- Feb 2026
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of PRGF-Endoret in intervertebral disc degeneration (DDD), low back pain (LBP), sponsored by BTI Biotechnology Institute. Started Jan 2025; status: recruiting.
02
Drugs
PRGF-Endoret
03
Conditions
intervertebral disc degeneration (DDD)low back pain (LBP)
Beyond the preview
Go deeper on NCT06715085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06715085.